A layer-by-layer gelatin nanocoating is presented for use as a tunable, dual response biomaterial for the capture and release of circulating tumor cells (CTCs) from cancer patient blood. The entire nanocoating can be dissolved from the surface of microfluidic devices through biologically compatible temperature shifts. Alternatively, individual CTCs can be released through locally applied mechanical stress.
No takes yet. Share an insight, caveat, or question.
Reátegui et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: